OpenURL Connection Search

Select item for more details and to access through your institution.

Insulin treatment improves liver histopathology and decreases expression of inflammatory and fibrogenic genes in a hyperglycemic, dyslipidemic hamster model of NAFLD.
Published in:
2021
By:
- Jensen, Victoria Svop;
- Fledelius, Christian;
- Zachodnik, Christina;
- Damgaard, Jesper;
- Nygaard, Helle;
- Tornqvist, Kristina Steinicke;
- Kirk, Rikke Kaae;
- Viuff, Birgitte Martine;
- Wulff, Erik Max;
- Lykkesfeldt, Jens;
- Hvid, Henning
Publication type:
journal article
PPARδ agonists have opposing effects on insulin resistance in high fat-fed rats and mice due to different metabolic responses in muscle.
Published in:
2011
By:
- Ye, Ji-Ming;
- Tid-Ang, Jennifer;
- Turner, Nigel;
- Zeng, Xiao-Yi;
- Li, Hai-Yan;
- Cooney, Gregory J.;
- Wulff, Erik Max;
- Sauerberg, Per;
- Kraegen, Edward W.
Publication type:
journal article
Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague-Dawley rats.
Published in:
Diabetology & Metabolic Syndrome, 2018, v. 10, p. 1, doi. 10.1186/s13098-018-0307-8
By:
- Jensen, Victoria Svop;
- Hvid, Henning;
- Damgaard, Jesper;
- Nygaard, Helle;
- Ingvorsen, Camilla;
- Wulff, Erik Max;
- Lykkesfeldt, Jens;
- Fledelius, Christian
Publication type:
Article
Author Correction: Molecular engineering of safe and efficacious oral basal insulin.
Published in:
2020
By:
- Hubálek, Frantisek;
- Refsgaard, Hanne H. F.;
- Gram-Nielsen, Sanne;
- Madsen, Peter;
- Nishimura, Erica;
- Münzel, Martin;
- Brand, Christian Lehn;
- Stidsen, Carsten Enggaard;
- Claussen, Christian Hove;
- Wulff, Erik Max;
- Pridal, Lone;
- Ribel, Ulla;
- Kildegaard, Jonas;
- Porsgaard, Trine;
- Johansson, Eva;
- Steensgaard, Dorte Bjerre;
- Hovgaard, Lars;
- Glendorf, Tine;
- Hansen, Bo Falck;
- Jensen, Maja Kirkegaard
Publication type:
Correction Notice
Molecular engineering of safe and efficacious oral basal insulin.
Published in:
Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17487-9
By:
- Hubálek, Frantisek;
- Refsgaard, Hanne H. F.;
- Gram-Nielsen, Sanne;
- Madsen, Peter;
- Nishimura, Erica;
- Münzel, Martin;
- Brand, Christian Lehn;
- Stidsen, Carsten Enggaard;
- Claussen, Christian Hove;
- Wulff, Erik Max;
- Pridal, Lone;
- Ribel, Ulla;
- Kildegaard, Jonas;
- Porsgaard, Trine;
- Johansson, Eva;
- Steensgaard, Dorte Bjerre;
- Hovgaard, Lars;
- Glendorf, Tine;
- Hansen, Bo Falck;
- Jensen, Maja Kirkegaard
Publication type:
Article
Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet.
Published in:
Nutrients, 2021, v. 13, n. 2, p. 604, doi. 10.3390/nu13020604
By:
- Svop Jensen, Victoria;
- Fledelius, Christian;
- Max Wulff, Erik;
- Lykkesfeldt, Jens;
- Hvid, Henning;
- Marchesini, Giulio
Publication type:
Article

Found: 6

Insulin treatment improves liver histopathology and decreases expression of inflammatory and fibrogenic genes in a hyperglycemic, dyslipidemic hamster model of NAFLD.

PPARδ agonists have opposing effects on insulin resistance in high fat-fed rats and mice due to different metabolic responses in muscle.

Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague-Dawley rats.

Author Correction: Molecular engineering of safe and efficacious oral basal insulin.

Molecular engineering of safe and efficacious oral basal insulin.

Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet.